ADHD Trial, Recruiting NCT06743425 Sponsor: IDeA States Pediatric Clinical Trials Network Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06743425
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Regarding the child:

  • The child must be under the care of a healthcare provider who is participating in this trial
  • The child must be between 5 and 11 years old at the time of joining
  • The child must have a diagnosis of ADHD
  • The child must be either starting stimulant medication for the very first time, or must not have taken stimulant medication in the past 6 months
  • The child must be attending elementary school in person

Regarding the primary caregiver:

  • The main caregiver must be legally able to give consent on the child's behalf and willing to do so
  • The main caregiver must have access to a smartphone
  • The main caregiver must speak English
  • The main caregiver must live with the child for at least 3 days per week
  • The main caregiver must complete an initial symptom assessment before the child starts stimulant treatment, and be willing to share a copy with the study team

Regarding the healthcare provider:

  • The provider must treat children aged 5–11 with ADHD
  • The provider must agree to the study's requirements, including using the RAMP platform for eligible patients and sharing information about the study with potential participants

Who may not be able to join:

Regarding the child:

  • Children who have serious mental health conditions such as schizophrenia, bipolar disorder, or conduct disorder, or who have ever been hospitalised for any mental health condition (note: children with depression, anxiety, or oppositional defiant disorder are permitted to participate)
  • Children who have severe neurodevelopmental disorders (note: children with well-controlled seizure disorders are permitted to participate)
  • Children who are currently taking, or have previously taken, a type of medication called atypical antipsychotics
  • Children who are pregnant or become pregnant during the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 501-686-7233

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IDeA States Pediatric Clinical Trials Network
Registry
ClinicalTrials.gov
Start date
4 February 2025
Est. completion
26 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluate completion of clinical assessments by caregivers and teachers.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov